Supplemental Financial Information (Tables)

12 Months Ended

Dec. 31, 2021

Balance Sheet Related Disclosures [Abstract]

Schedule of Property, Plant and Equipment

Property, Plant and Equipment, net consisted of the following (in thousands):

	December 31, 2021			December 31, 2020
Leasehold improvements	$	2,067		$	—
Furniture and fixtures		845			—
Computer equipment		1,098			95
Laboratory equipment		1,095			—
Construction in progress		46,004			201
		51,109			296
Accumulated depreciation		(499	)		(9	)
Property, plant and equipment, net	$	50,610		$	287

Schedule of Accrued Expenses and Other Current Labilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	December 31, 2021		December 31, 2020
Accrued research and development	$	11,895	$	2,106
Accrued compensation		7,703		1,766
Accrued license fees		3,500		—
Accrued property, plant, and equipment		2,644		173
Accrued clinical trials		1,659		—
Accrued professional and consulting fees		1,091		999
Other		1,491		91
Total accrued expenses and other current liabilities	$	29,983	$	5,135

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	December 31, 2021		December 31, 2020
Prepaid research and development	$	5,218	$	2,462
Prepaid clinical trial		3,298		944
Deferred offering costs		545		—
Prepaid bonus		427		409
Prepaid insurance		148		2,480
Other		863		331
Total prepaid expenses and other current assets	$	10,499	$	6,626